| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7291132 | LILLY | Medication dispensing apparatus with triple screw threads for mechanical advantage |
Aug, 2024
(3 months from now) | |
Humulin R is owned by Lilly.
Humulin R contains Insulin Recombinant Human.
Humulin R has a total of 1 drug patent out of which 0 drug patents have expired.
Humulin R was authorised for market use on 29 December, 2015.
Humulin R is available in injectable;injection dosage forms.
The generics of Humulin R are possible to be released after 09 August, 2024.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NR(NR) | Mar 25, 2014 |
Drugs and Companies using INSULIN RECOMBINANT HUMAN ingredient
Market Authorisation Date: 29 December, 2015
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
HUMULIN R family patents
